Nothing written yet for this company.
Medy-Tox, Inc. (086900) raised its damages claim against Daewoong Pharma (069620) to ₩500 billion, Dailian reported Friday.
| Period | 069620 | KOSPI | Difference |
|---|---|---|---|
| 1 week | -9.9% | -1.5% | -8.4% |
| 1 month | -6.1% | +5.2% | -11.2% |
| 3 months | -8.2% | -22.6% | +14.4% |
| 6 months | -25.6% | +31.3% | -56.9% |
| Year to date | -32.6% | +58.7% | -91.3% |
| 1 year | -18.3% | +108.9% | -127.2% |
Closed at 10% of the way from its 52-week low (₩107,300) to its 52-week high (₩194,000).
Daewoong Pharma makes prescription medicines in South Korea. It is listed on KOSPI, was founded in 2002, is based in Gyeonggi, and has revenue of a few trillion won.
| Sector | Biopharma | Employees | |
| Market | KOSPI | Founded | 2002 |
| Korean name | 대웅제약 | Head office | Gyeonggi |
| Symbol | Last Price |
|---|---|
| 068760Celltrion Pharm, Inc. | ₩40,850 +0.0% |
| 007390Naturecell Co., Ltd. | ₩23,950 +0.2% |
| 006280GC Biopharma Corp. | ₩127,600 +0.5% |
| 950160Kolon Tissue Gene, Inc. | ₩17,100 +1.1% |
| 039200Oscotec, Inc. | ₩36,600 +1.9% |
| 290650L & C BIO Co., Ltd. | ₩47,900 -1.4% |
| 127120JS Link | ₩33,600 +12.4% |
| 475830Orum Therapeutics, Inc. | ₩55,900 +2.6% |
| 195940HK inno.N Corporation | ₩42,050 +0.7% |
| 003090Daewoong Co., Ltd. | ₩16,860 -2.0% |